Tumor Hyperinsulinism (Tumor HI) research hub

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

This study is testing a new drug, Ersodetug, for adults with a rare condition called Tumour Hyperinsulinism (Tumour HI). It aims to see if the drug can help control very low blood sugar levels caused by certain tumours, when current treatments aren't enough.